PREPARE: A Randomized Trial of a Pre-pregnancy Weight Loss Intervention
1 other identifier
interventional
326
1 country
1
Brief Summary
The US obesity epidemic is being transmitted to the next generation. Growing evidence suggests that both a mothers' weight at pregnancy onset, and excessive weight gain during pregnancy, are associated with increased risk of pregnancy-related complications such as gestational diabetes and pre-eclampsia, and an increased risk that her child will become obese and face obesity-related health issues in later life. Currently, over one-third of reproductive-aged women in the U.S. are obese \[body mass index (BMI) ≥ 30\]. Our research team has shown that we can improve birth weight outcomes in babies of obese women who start a weight-management intervention program at 14 to 15 weeks of their pregnancy (soon after their first prenatal visit). However, organogenesis and metabolic programming begin early in the first trimester, well before the first prenatal visit. Therefore, waiting to address mothers' weight, physical activity, and diet quality until the first prenatal visit is not optimal. Given the need to reach overweight and obese women prior to pregnancy, and the Institute of Medicine's (IOM's) recent recommendation, based on observational studies, that women should reach a healthy weight before conceiving, this randomized clinical trial will evaluate a comprehensive preconception weight loss program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2015
CompletedFirst Posted
Study publicly available on registry
January 26, 2015
CompletedStudy Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2019
CompletedApril 5, 2022
April 1, 2022
4.1 years
January 20, 2015
April 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduced pregnancy-related weight gain
1 day at the end of pregnancy
Secondary Outcomes (2)
Lower weight at the start of pregnancy
Self-reported pre-pregnancy weight supplemented by weight at first prenatal visit (1 day)
Decreased risk of exceeding national norms for weight at birth
birth
Study Arms (2)
Intervention
EXPERIMENTALWeight management intervention
Usual Care Control
OTHERUsual Care for planning healthy pregnancy
Interventions
Phone counseling for pre-pregnancy weight loss and weight maintenance when BMI \</=25, and when pregnant, weight gain within IOM guidelines.
Usual care control participants receive general dietary advice as it relates to planning for a healthy pregnancy (e.g. folate requirements, prenatal vitamins, smoking cessation, alcohol cessation, and prenatal food safety).
Eligibility Criteria
You may qualify if:
- Current Kaiser Permanente Northwest (KPNW) member
- Expects to be KPNW member for at least 2 more years
- Body Mass Index (BMI) ≥ 27
- Not currently pregnant
- Access to computer with Internet
- Completion of screening diet assessment
- English speaking
You may not qualify if:
- Taking medication (insulin or pills) for treatment of diabetes
- Gastrointestinal disease requiring special diet or medications (for example, ulcerative colitis, celiac sprue, phenylketonuria)
- Currently receiving treatment for cancer
- Renal disease (kidney disease requiring special diet or medication)
- History of bariatric surgery
- Use of prescription weight loss medications in the last three months
- Another household member already participating in the Prepare study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Anna Edelmann
Portland, Oregon, 97227, United States
Related Publications (3)
LeBlanc ES, Smith NX, Vesco KK, Paul IM, Stevens VJ. Weight loss prior to pregnancy and subsequent gestational weight gain: Prepare, a randomized clinical trial. Am J Obstet Gynecol. 2021 Jan;224(1):99.e1-99.e14. doi: 10.1016/j.ajog.2020.07.027. Epub 2020 Jul 18.
PMID: 32687819RESULTLeBlanc ES, Boisvert C, Catlin C, Lee MH, Smith N, Vesco KK, Savage J, Mitchell DC, Gruss I, Stevens VJ. Prepare randomized clinical trial: Acceptability, engagement, and lifestyle effects of a weight loss intervention beginning in pre-pregnancy. Obes Sci Pract. 2022 Feb 24;8(5):603-616. doi: 10.1002/osp4.596. eCollection 2022 Oct.
PMID: 36238226DERIVEDLeBlanc ES, Smith NX, Vesco KK, Hillier TA, Stevens VJ. Weight Loss Prior to Pregnancy and Early Gestational Glycemia: Prepare, a Randomized Clinical Trial. J Clin Endocrinol Metab. 2021 Nov 19;106(12):e5001-e5010. doi: 10.1210/clinem/dgab547.
PMID: 34313765DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erin S LeBlanc, MD
Center for Health Research, Kaiser Permanente Northwest
- PRINCIPAL INVESTIGATOR
Victor J Stevens, PhD
Center for Health Research, Kaiser Permanente Northwest
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2015
First Posted
January 26, 2015
Study Start
June 1, 2015
Primary Completion
June 21, 2019
Study Completion
June 21, 2019
Last Updated
April 5, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share
Any information from this study we present in reports or publications will not identify any individual.